: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.

Influenza

Free Subscription

Articles published in J Virol
Retrieve available abstracts of 252 articles:
HTML format

Single Articles

May 2025

KOUTSAKOS M, Reynaldi A, Aban M, Barr IG, et al
Binding antibody titers against the hemagglutinin and neuraminidase correlate with protection against medically attended influenza A and B disease.
J Virol. 2025 May 13:e0039125. doi: 10.1128/jvi.00391.
PubMed Abstract available

XIE Z, Yang J, Jiao W, Li X, et al
Clade 2.3.4.4b highly pathogenic avian influenza H5N1 viruses: knowns, unknowns, and challenges.
J Virol. 2025 May 9:e0042425. doi: 10.1128/jvi.00424.
PubMed Abstract available

LI Y, Quan X, Chen R, Wang X, et al
Adaptive selection of quasispecies during in vivo passaging in chickens, mice, and ferrets results in host-specific strains for the H9N2 avian influenza virus.
J Virol. 2025 May 8:e0015125. doi: 10.1128/jvi.00151.
PubMed Abstract available

April 2025

LE CTT, Kim K-H, Raha JR, Bhatnagar N, et al
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination.
J Virol. 2025 Apr 23:e0229424. doi: 10.1128/jvi.02294.
PubMed Abstract available

LOWEN AC, Baker AL, Bowman AS, Garcia-Sastre A, et al
Pandemic risk stemming from the bovine H5N1 outbreak: an account of the knowns and unknowns.
J Virol. 2025;99:e0005225.
PubMed Abstract available

ADU OF, Sempere Borau M, Fruh SP, Karakus U, et al
Cell binding, uptake, and infection of influenza A virus using recombinant antibody-based receptors.
J Virol. 2025 Apr 10:e0227524. doi: 10.1128/jvi.02275.
PubMed Abstract available

XU S, Liu Y, Luo C, Zhou M, et al
Identification and characterization of a broadly neutralizing and protective nanobody against the HA1 domain of H5 avian influenza virus hemagglutinin.
J Virol. 2025 Apr 7:e0209024. doi: 10.1128/jvi.02090.
PubMed Abstract available

XIAO X, Wang X, Xu F, Liang Y, et al
Synergistic effects of PA (S184N) and PB2 (E627K) mutations on the increased pathogenicity of H3N2 canine influenza virus infections in mice and dogs.
J Virol. 2025 Apr 4:e0198424. doi: 10.1128/jvi.01984.
PubMed Abstract available

March 2025

KRAMMER F, Hermann E, Rasmussen AL
Highly pathogenic avian influenza H5N1: history, current situation, and outlook.
J Virol. 2025 Mar 27:e0220924. doi: 10.1128/jvi.02209.
PubMed Abstract available

YU L, Jiang Y, Rang H, Wang X, et al
Restriction of influenza A virus replication by host DCAF7-CRL4B axis.
J Virol. 2025 Mar 27:e0013325. doi: 10.1128/jvi.00133.
PubMed Abstract available

JANA ID, Kanjo K, Roy S, Bhasin M, et al
Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants.
J Virol. 2025 Mar 26:e0005125. doi: 10.1128/jvi.00051.
PubMed Abstract available

LI P, Faraone JN, Hsu CC, Chamblee M, et al
Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.
J Virol. 2025 Mar 26:e0024225. doi: 10.1128/jvi.00242.
PubMed Abstract available

LANG Y, Shi L, Roy S, Gupta D, et al
Detection of antibodies against influenza A viruses in cattle.
J Virol. 2025 Mar 25:e0213824. doi: 10.1128/jvi.02138.
PubMed Abstract available

JOHN K, Huntress I, Smith E, Chou H, et al
Human long noncoding RNA VILMIR is induced by major respiratory viral infections and modulates the host interferon response.
J Virol. 2025 Mar 25:e0014125. doi: 10.1128/jvi.00141.
PubMed Abstract available

DADONAITE B, Burrell AR, Logue J, Chu HY, et al
SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals.
J Virol. 2025 Mar 25:e0010925. doi: 10.1128/jvi.00109.
PubMed Abstract available

BEAVIS AC, Xiao P, Gingerich MC, Briggs K, et al
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates.
J Virol. 2025 Mar 21:e0199024. doi: 10.1128/jvi.01990.
PubMed Abstract available

BEAVIS AC, Li Z, Briggs K, Gingerich MC, et al
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants.
J Virol. 2025 Mar 21:e0198924. doi: 10.1128/jvi.01989.
PubMed Abstract available

SIMS A, Weir DJ, Cole SJ, Hutchinson E, et al
SARS-CoV-2 cellular coinfection is limited by superinfection exclusion.
J Virol. 2025 Mar 21:e0207724. doi: 10.1128/jvi.02077.
PubMed Abstract available

HU H, Zhang Y, Zheng H, Zhao X, et al
Thymic stromal lymphopoietin improves protective immunity of the SARS-CoV-2 subunit vaccine by inducing dendritic cell-dependent germinal center response.
J Virol. 2025 Mar 4:e0232324. doi: 10.1128/jvi.02323.
PubMed Abstract available

KARL V, Hofmann M, Thimme R
Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination.
J Virol. 2025 Mar 3:e0135024. doi: 10.1128/jvi.01350.
PubMed Abstract available

February 2025

QU X, Zhu Z, Zhou X, Wu X, et al
KRT9 is required for GBP5 suppression of human respiratory syncytial virus.
J Virol. 2025;99:e0202924.
PubMed Abstract available

MILLER JL, Leedale C, Kang D, Lilue J, et al
Prostaglandin D2 delays CD8+ T-cell responses and respiratory syncytial virus clearance in geriatric cotton rats.
J Virol. 2025;99:e0186324.
PubMed Abstract available

HAO T, Xie Y, Chai Y, Zhang W, et al
Structural basis of receptor-binding adaptation of human-infecting H3N8 influenza A virus.
J Virol. 2025 Feb 24:e0106524. doi: 10.1128/jvi.01065.
PubMed Abstract available

KOBAYASHI D, Hiono T, Arakawa H, Kaji H, et al
Deglycosylation and truncation in the neuraminidase stalk are functionally equivalent in enhancing the pathogenicity of a high pathogenicity avian influenza virus in chickens.
J Virol. 2025 Feb 14:e0147824. doi: 10.1128/jvi.01478.
PubMed Abstract available

MA R, Zhang X, Li R, Dong X, et al
PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2.
J Virol. 2025 Feb 13:e0208524. doi: 10.1128/jvi.02085.
PubMed Abstract available

FURUSAWA Y, Kiso M, Uraki R, Sakai-Tagawa Y, et al
Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures.
J Virol. 2025 Feb 12:e0221724. doi: 10.1128/jvi.02217.
PubMed Abstract available

KUHN AJ, Outlaw VK, Marcink TC, Yu Z, et al
Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects for clinical development.
J Virol. 2025 Feb 4:e0215924. doi: 10.1128/jvi.02159.
PubMed Abstract available

PHAN T, Ribeiro RM, Edelstein GE, Boucau J, et al
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance.
J Virol. 2025 Feb 4:e0162324. doi: 10.1128/jvi.01623.
PubMed Abstract available

WANG X, Dong M, Wu X, Schnepf D, et al
Single-cell transcriptomics reveals a compartmentalized antiviral interferon response in the nasal epithelium of mice.
J Virol. 2025 Feb 4:e0141324. doi: 10.1128/jvi.01413.
PubMed Abstract available

PARK H, Kingstad-Bakke B, Cleven T, Jung M, et al
Diversifying T-cell responses: safeguarding against pandemic influenza with mosaic nucleoprotein.
J Virol. 2025 Feb 3:e0086724. doi: 10.1128/jvi.00867.
PubMed Abstract available

January 2025

KIRKPATRICK ROUBIDOUX E, Meliopoulos V, Livingston B, Brigleb PH, et al
Intraductal infection with H5N1 clade 2.3.4.4b influenza virus.
J Virol. 2025 Jan 31:e0192724. doi: 10.1128/jvi.01927.
PubMed

ZHAO B, Sun Z, Wang S, Shi Z, et al
Structural basis of different neutralization capabilities of monoclonal antibodies against H7N9 virus.
J Virol. 2025;99:e0140024.
PubMed Abstract available

SAMAAN P, Korosec CS, Budylowski P, Chau SLL, et al
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-gamma and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity.
J Virol. 2025 Jan 31:e0168524. doi: 10.1128/jvi.01685.
PubMed Abstract available

LYTRAS S, Lamb KD, Ito J, Grove J, et al
Pathogen genomic surveillance and the AI revolution.
J Virol. 2025 Jan 29:e0160124. doi: 10.1128/jvi.01601.
PubMed Abstract available

WANG Y, Xia B, Gao Z
A comprehensive review of current insights into the virulence factors of SARS-CoV-2.
J Virol. 2025 Jan 29:e0204924. doi: 10.1128/jvi.02049.
PubMed Abstract available

SADLER HL, Rijal P, Tan TK, Townsend ARM, et al
A locally administered single-cycle influenza vaccine expressing a non-fusogenic stabilized hemagglutinin stimulates strong T-cell and neutralizing antibody immunity.
J Virol. 2025 Jan 27:e0033124. doi: 10.1128/jvi.00331.
PubMed Abstract available

FOO IJH, Chua BY, Chang SY, Jia X, et al
Prior influenza virus infection alleviates an arbovirus encephalitis by reducing viral titer, inflammation, and cellular infiltrates in the central nervous system.
J Virol. 2025 Jan 16:e0210824. doi: 10.1128/jvi.02108.
PubMed Abstract available

NAGHIBOSADAT M, Babuadze GG, Pei Y, Hurst J, et al
Vaccination against SARS-CoV-2 provides low-level cross-protection against common cold coronaviruses in mouse and non-human primate animal models.
J Virol. 2025 Jan 16:e0139024. doi: 10.1128/jvi.01390.
PubMed Abstract available

CAI C, Pham TNQ, Adam D, Brochiero E, et al
Sensing of SARS-CoV-2-infected cells by plasmacytoid dendritic cells is modulated via an interplay between CD54/ICAM-1 and CD11a/LFA-1 alpha(L) integrin.
J Virol. 2025 Jan 13:e0123524. doi: 10.1128/jvi.01235.
PubMed Abstract available

PERRY SS, Brice DC, Sakr AA, Kandeil A, et al
Modulation of cytokeratin and cytokine/chemokine expression following influenza virus infection of differentiated human tonsillar epithelial cells.
J Virol. 2025 Jan 10:e0146024. doi: 10.1128/jvi.01460.
PubMed Abstract available

FOX CR, Yousef NN, Varudkar N, Shiffer EM, et al
Resistance to complement-mediated lysis of parainfluenza virus 5-infected cells is acquired after transition from acute to persistent infection.
J Virol. 2025 Jan 10:e0189524. doi: 10.1128/jvi.01895.
PubMed Abstract available

ARORA P, Zhang L, Nehlmeier I, Kempf A, et al
Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484D.
J Virol. 2025 Jan 10:e0123024. doi: 10.1128/jvi.01230.
PubMed Abstract available

HU H, Leng C, Shu Y, Peng L, et al
Structural insights into hybridoma-derived neutralizing monoclonal antibodies against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2.
J Virol. 2025 Jan 7:e0130724. doi: 10.1128/jvi.01307.
PubMed Abstract available

GUNAWARDENE CD, Wong L-YR
Betacoronavirus internal protein: role in immune evasion and viral pathogenesis.
J Virol. 2025 Jan 6:e0135324. doi: 10.1128/jvi.01353.
PubMed Abstract available

December 2024

CAI Z, Ni W, Li W, Wu Z, et al
SARS-CoV-2 S protein disrupts the formation of ISGF3 complex through conserved S2 subunit to antagonize type I interferon response.
J Virol. 2024 Dec 19:e0151624. doi: 10.1128/jvi.01516.
PubMed Abstract available

XIONG Y, Tao K, Li T, Zhou Y, et al
Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein.
J Virol. 2024;98:e0153624.
PubMed Abstract available

NEAL HE, Barrett CT, Edmonds K, Moncman CL, et al
Examination of respiratory syncytial virus fusion protein proteolytic processing and roles of the P27 domain.
J Virol. 2024;98:e0163924.
PubMed Abstract available

TAKAHASHI T, Amarbayasgalan S, Ueno S, Sugiura Y, et al
Lethal model for respiratory syncytial virus infection using C57BL/6 mice.
J Virol. 2024;98:e0177224.
PubMed Abstract available

LV H, Teo QW, Lee C-CD, Liang W, et al
Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model.
J Virol. 2024 Dec 5:e0169524. doi: 10.1128/jvi.01695.
PubMed Abstract available

YANG K, Nizami S, Hu S, Zou L, et al
Genetic diversity of highly pathogenic avian influenza H5N6 and H5N8 viruses in poultry markets in Guangdong, China, 2020-2022.
J Virol. 2024 Dec 4:e0114524. doi: 10.1128/jvi.01145.
PubMed Abstract available

November 2024

KAKIZAKI M, Hashimoto R, Nagata N, Yamamoto T, et al
The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.
J Virol. 2024 Nov 27:e0185324. doi: 10.1128/jvi.01853.
PubMed Abstract available

SHETTY N, Shephard MJ, Rockey NC, Macenczak H, et al
Influenza virus infection and aerosol shedding kinetics in a controlled human infection model.
J Virol. 2024 Nov 26:e0161224. doi: 10.1128/jvi.01612.
PubMed Abstract available

FUJIMOTO Y, Ozaki K, Ono E
Chicken ANP32A-independent replication of highly pathogenic avian influenza viruses potentially leads to mammalian adaptation-related amino acid substitutions in viral PB2 and PA proteins.
J Virol. 2024 Nov 21:e0184024. doi: 10.1128/jvi.01840.
PubMed Abstract available

BOLLAND W, Marechal I, Petiot C, Porrot F, et al
SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts.
J Virol. 2024 Nov 21:e0182324. doi: 10.1128/jvi.01823.
PubMed Abstract available

PATINO-GALINDO J, Garcia-Sastre A, Kuhn JH, Rabadan R, et al
Recombination across distant coronavirid species and genera is a rare event with distinct genomic features.
J Virol. 2024 Nov 19:e0110024. doi: 10.1128/jvi.01100.
PubMed Abstract available

LI C, Culhane MR, Schroeder DC, Cheeran MC-J, et al
Quantifying the impact of vaccination on transmission and diversity of influenza A variants in pigs.
J Virol. 2024 Nov 12:e0124524. doi: 10.1128/jvi.01245.
PubMed Abstract available

POWELL JD, Thomas MN, Anderson TK, Zeller MA, et al
2018-2019 human seasonal H3N2 influenza A virus spillovers into swine with demonstrated virus transmission in pigs were not sustained in the pig population.
J Virol. 2024 Nov 11:e0008724. doi: 10.1128/jvi.00087.
PubMed Abstract available

CHEN D, Zhang W, Xiao B, Xu B, et al
Effect of wild-type vaccine doses on BA.5 hybrid immunity, disease severity, and XBB reinfection risk.
J Virol. 2024 Nov 5:e0128524. doi: 10.1128/jvi.01285.
PubMed Abstract available

SUN X, Belser JA, Pulit-Penaloza JA, Brock N, et al
Dissecting the role of the HA1-226 leucine residue in the fitness and airborne transmission of an A(H9N2) avian influenza virus.
J Virol. 2024 Nov 4:e0092824. doi: 10.1128/jvi.00928.
PubMed Abstract available

STEIN SC, Hansen G, Ssebyatika G, Stroh LJ, et al
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation.
J Virol. 2024 Nov 4:e0122324. doi: 10.1128/jvi.01223.
PubMed Abstract available

PARRY RH, Lytras S, Petrone ME, Wille M, et al
No evidence that mutations in SARS-CoV-2 variants of concern derive from homologous fragments in gut microbiota.
J Virol. 2024 Nov 4:e0146824. doi: 10.1128/jvi.01468.
PubMed Abstract available

October 2024

ZHANG C, Jiang Q, Liu Z, Li N, et al
SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor.
J Virol. 2024 Oct 24:e0075424. doi: 10.1128/jvi.00754.
PubMed Abstract available

SHAHRIARI S, Ghildyal R
The actin-binding protein palladin associates with the respiratory syncytial virus matrix protein.
J Virol. 2024;98:e0143524.
PubMed Abstract available

FAURE-DUPUY S, Depierre M, Fremont-Debaene Z, Herit F, et al
Human rhinovirus 16 induces an ICAM-1-PKR-ATF2 axis to modulate macrophage functions.
J Virol. 2024;98:e0149924.
PubMed Abstract available

HAN Y, Zhou H, Liu C, Wang W, et al
SARS-CoV-2 N protein coordinates viral particle assembly through multiple domains.
J Virol. 2024 Oct 16:e0103624. doi: 10.1128/jvi.01036.
PubMed Abstract available

TRIMARCO JD, Spurrier MA, Skavicus S, Luo Z, et al
Fluorescent and bioluminescent bovine H5N1 influenza viruses for evaluation of antiviral interventions.
J Virol. 2024 Oct 10:e0138524. doi: 10.1128/jvi.01385.
PubMed Abstract available

LI A, Zhao K, Duan Y, Zhang B, et al
SARS-CoV-2 nsp13 suppresses hepatitis B virus replication by targeting cccDNA transcription.
J Virol. 2024 Oct 7:e0104224. doi: 10.1128/jvi.01042.
PubMed Abstract available

WANG W, Bhushan G, Paz S, Stauft CB, et al
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1.
J Virol. 2024 Oct 4:e0094824. doi: 10.1128/jvi.00948.
PubMed Abstract available

DO THT, Wille M, Wheatley AK, Koutsakos M, et al
Triton X-100-treated virus-based ELLA demonstrates discordant antigenic evolution of influenza B virus hemagglutinin and neuraminidase.
J Virol. 2024 Oct 3:e0118624. doi: 10.1128/jvi.01186.
PubMed Abstract available

September 2024

HAMELE CE, Luo Z, Leonard RA, Spurrier MA, et al
Headless hemagglutinin-containing influenza viral particles direct immune responses toward more conserved epitopes.
J Virol. 2024 Sep 26:e0116624. doi: 10.1128/jvi.01166.
PubMed Abstract available

LOES AN, Tarabi RAL, Huddleston J, Touyon L, et al
High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains.
J Virol. 2024 Sep 24:e0068924. doi: 10.1128/jvi.00689.
PubMed Abstract available

DAVID SC, Schaub A, Terrettaz C, Motos G, et al
Correction for David et al., "Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria".
J Virol. 2024 Sep 19:e0122224. doi: 10.1128/jvi.01222.
PubMed

WANG Z, Qiu M, Ji Y, Chai K, et al
Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation.
J Virol. 2024 Sep 17:e0107224. doi: 10.1128/jvi.01072.
PubMed Abstract available

BROOKS K, Nelson CE, Aguilar C, Hoang TN, et al
SARS-CoV-2 infection perturbs the gastrointestinal tract and induces modest microbial translocation across the intestinal barrier.
J Virol. 2024 Sep 12:e0128824. doi: 10.1128/jvi.01288.
PubMed Abstract available

HAN M, Lu Q, Wang D, Zhou K, et al
Oral co-administration of Lactiplantibacillus plantarum 16 and Lacticaseibacillus rhamnosus P118 improves host defense against influenza A virus infection.
J Virol. 2024 Sep 11:e0095024. doi: 10.1128/jvi.00950.
PubMed Abstract available

SOUDANI N, Bricker TL, Darling T, Seehra K, et al
Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters.
J Virol. 2024 Sep 4:e0052824. doi: 10.1128/jvi.00528.
PubMed Abstract available

GUAN M, DeLiberto TJ, Feng A, Zhang J, et al
Neu5Gc binding loss of subtype H7 influenza A virus facilitates adaptation to gallinaceous poultry following transmission from waterbirds.
J Virol. 2024 Sep 3:e0011924. doi: 10.1128/jvi.00119.
PubMed Abstract available

August 2024

YANG Y, Xu C, Zhang N, Wan Y, et al
Two amino acid residues in the N-terminal region of the polymerase acidic protein determine the virulence of Eurasian avian-like H1N1 swine influenza viruses in mice.
J Virol. 2024 Aug 30:e0129324. doi: 10.1128/jvi.01293.
PubMed Abstract available

BARRETO-DURAN E, Synowiec A, Szczepanski A, Galuszka-Bulaga A, et al
Development of an intestinal mucosa ex vivo co-culture model to study viral infections.
J Virol. 2024 Aug 30:e0098724. doi: 10.1128/jvi.00987.
PubMed Abstract available

HU Y, Jin Y, Han D, Zhang G, et al
Correction for Hu et al., "Mast Cell-Induced Lung Injury in Mice Infected with H5N1 Influenza Virus".
J Virol. 2024 Aug 29:e0110624. doi: 10.1128/jvi.01106.
PubMed

ALFADHLI A, Bates TA, Barklis RL, Romanaggi C, et al
A nanobody interaction with SARS-COV-2 Spike allows the versatile targeting of lentivirus vectors.
J Virol. 2024 Aug 29:e0079524. doi: 10.1128/jvi.00795.
PubMed Abstract available

DMYTRENKO O, Das S, Kovacs A, Cicka M, et al
Infiltrating monocytes drive cardiac dysfunction in a cardiomyocyte-restricted mouse model of SARS-CoV-2 infection.
J Virol. 2024 Aug 29:e0117924. doi: 10.1128/jvi.01179.
PubMed Abstract available

LIEBER CM, Kang H-J, Sobolik EB, Sticher ZM, et al
Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection.
J Virol. 2024 Aug 29:e0090524. doi: 10.1128/jvi.00905.
PubMed Abstract available

GOODWIN E, Gibbs JS, Yewdell JW, Eisenlohr LC, et al
Influenza virus antibodies inhibit antigen-specific de novo B cell responses in mice.
J Virol. 2024 Aug 28:e0076624. doi: 10.1128/jvi.00766.
PubMed Abstract available

HARTWIG SM, Odle A, Wong L-YR, Meyerholz DK, et al
Respiratory syncytial virus infection provides protection against severe acute respiratory syndrome coronavirus challenge.
J Virol. 2024 Aug 28:e0066924. doi: 10.1128/jvi.00669.
PubMed Abstract available

YING B, Liang C-Y, Desai P, Scheaffer SM, et al
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain.
J Virol. 2024 Aug 28:e0057424. doi: 10.1128/jvi.00574.
PubMed Abstract available

ZHU J, Liu G, Sayyad Z, Goins CM, et al
ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis.
J Virol. 2024 Aug 28:e0086924. doi: 10.1128/jvi.00869.
PubMed Abstract available

TERASAKI K, Makino S
Requirement of the N-terminal region of nonstructural protein 1 in cis for SARS-CoV-2 defective RNA replication.
J Virol. 2024 Aug 28:e0090024. doi: 10.1128/jvi.00900.
PubMed Abstract available

WANG G, Verma AK, Guan X, Bu F, et al
Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge.
J Virol. 2024 Aug 27:e0037624. doi: 10.1128/jvi.00376.
PubMed Abstract available

UNO N, Ebensen T, Guzman CA, Ross TM, et al
Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses.
J Virol. 2024 Aug 22:e0035424. doi: 10.1128/jvi.00354.
PubMed Abstract available

WANG L, Shi L, Liu H, Zhang J, et al
Incompatible packaging signals and impaired protein functions hinder reassortment of bat H17N10 or H18N11 segment 7 with human H1N1 influenza A viruses.
J Virol. 2024 Aug 20:e0086424. doi: 10.1128/jvi.00864.
PubMed Abstract available

GAO Y, Raghavan A, Espinosa Garcia SA, Deng B, et al
In vitro higher-order oligomeric assembly of the respiratory syncytial virus M2-1 protein with longer RNAs.
J Virol. 2024;98:e0104624.
PubMed Abstract available

MUSA AO, Faber SR, Forrest K, Smith KP, et al
Identification of distinct genotypes in circulating RSV A strains based on variants in the virus replication-associated genes.
J Virol. 2024;98:e0099024.
PubMed Abstract available

BARBOSA BOMFIM CC, Genin H, Cottoignies-Callamarte A, Gallois-Montbrun S, et al
CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients.
J Virol. 2024 Aug 20:e0012824. doi: 10.1128/jvi.00128.
PubMed Abstract available

RHAMADIANTI AF, Abe T, Tanaka T, Ono C, et al
SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity.
J Virol. 2024 Aug 9:e0085524. doi: 10.1128/jvi.00855.
PubMed Abstract available

ALWINE J, Goodrum F, Banfield B, Bloom D, et al
The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without evidence.
J Virol. 2024 Aug 1:e0124024. doi: 10.1128/jvi.01240.
PubMed Abstract available

July 2024

AMOAH S, Cao W, Sayedahmed EE, Wang Y, et al
The frequency and function of nucleoprotein-specific CD8(+) T cells are critical for heterosubtypic immunity against influenza virus infection.
J Virol. 2024 Jul 31:e0071124. doi: 10.1128/jvi.00711.
PubMed Abstract available

WIGGINS KB, Winston SM, Reeves IL, Gaevert J, et al
rAAV expressing a COBRA-designed influenza hemagglutinin generates a protective and durable adaptive immune response with a single dose.
J Virol. 2024 Jul 30:e0078124. doi: 10.1128/jvi.00781.
PubMed Abstract available

SPACKMAN E, Jones DR, McCoig AM, Colonius TJ, et al
Characterization of highly pathogenic avian influenza virus in retail dairy products in the US.
J Virol. 2024 Jul 3:e0088124. doi: 10.1128/jvi.00881.
PubMed Abstract available

RICHARDSON SI, Mzindle N, Motlou T, Manamela NP, et al
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcgammaRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.
J Virol. 2024 Jul 2:e0067824. doi: 10.1128/jvi.00678.
PubMed Abstract available

June 2024

YU X, Tian J, Wang Y, Su N, et al
The pseudogene GBP1P1 suppresses influenza A virus replication by acting as a protein decoy for DHX9.
J Virol. 2024 Jun 28:e0073824. doi: 10.1128/jvi.00738.
PubMed Abstract available

PECHOUS RD, Malaviarachchi PA, Banerjee SK, Byrum SD, et al
An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy.
J Virol. 2024 Jun 28:e0079424. doi: 10.1128/jvi.00794.
PubMed Abstract available

CHEN Z, Cui Q, Ran Y, Achi JG, et al
A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.
J Virol. 2024 Jun 20:e0050424. doi: 10.1128/jvi.00504.
PubMed Abstract available

STAHL-HENNIG C, Peter AS, Cordsmeier A, Stolte-Leeb N, et al
Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model.
J Virol. 2024 Jun 20:e0062824. doi: 10.1128/jvi.00628.
PubMed Abstract available

PAN R, Li P, Meyerholz DK, Perlman S, et al
Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice.
J Virol. 2024 Jun 18:e0058424. doi: 10.1128/jvi.00584.
PubMed Abstract available

ZHU J, Wang Z, Li Y, Zhang Z, et al
Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior protection against lethal SARS-CoV-2 challenge in mice.
J Virol. 2024 Jun 14:e0052124. doi: 10.1128/jvi.00521.
PubMed Abstract available

DAVID SC, Schaub A, Terrettaz C, Motos G, et al
Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.
J Virol. 2024 Jun 13:e0040924. doi: 10.1128/jvi.00409.
PubMed Abstract available

May 2024

HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
Correction for Huang et al., "N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies".
J Virol. 2024 May 31:e0112823. doi: 10.1128/jvi.01128.
PubMed

CARTER DM, Darby CA, Lefoley BC, Crevar CJ, et al
Correction for Carter et al., "Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses".
J Virol. 2024 May 31:e0181323. doi: 10.1128/jvi.01813.
PubMed

CARTER DM, Darby CA, Johnson SK, Carlock MA, et al
Retraction for Carter et al., "Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses".
J Virol. 2024 May 31:e0183223. doi: 10.1128/jvi.01832.
PubMed

RAHMAN SM, Buchholz DW, Imbiakha B, Jager MC, et al
Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signs.
J Virol. 2024 May 30:e0006624. doi: 10.1128/jvi.00066.
PubMed Abstract available

MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al
A community science approach to public health and public trust in science.
J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825.
PubMed Abstract available

KNOLL M, Honce R, Meliopoulos V, Segredo-Otero EA, et al
Host obesity impacts genetic variation in influenza A viral populations.
J Virol. 2024 May 24:e0177823. doi: 10.1128/jvi.01778.
PubMed Abstract available

SCHWAB LSU, Do THT, Pilapitiya D, Koutsakos M, et al
Dissemination of influenza B virus to the lower respiratory tract of mice is restricted by the interferon response.
J Virol. 2024 May 23:e0160423. doi: 10.1128/jvi.01604.
PubMed Abstract available

MA MT, Jiang Q, Chen C-H, Badeti S, et al
S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.
J Virol. 2024 May 20:e0003824. doi: 10.1128/jvi.00038.
PubMed Abstract available

MEADE PS, Bandawane P, Bushfield K, Hoxie I, et al
Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City.
J Virol. 2024 May 15:e0062624. doi: 10.1128/jvi.00626.
PubMed Abstract available

CESAR RAMOS DE JESUS H, Solis N, Machado Y, Pablos I, et al
Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL(pro) main protease (Mpro) from proteomic identification of P6-P6' active site specificity.
J Virol. 2024 May 14:e0004924. doi: 10.1128/jvi.00049.
PubMed Abstract available

YU M, Li J, Gao W, Li Z, et al
Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
J Virol. 2024 May 6:e0162423. doi: 10.1128/jvi.01624.
PubMed Abstract available

April 2024

VIOX EG, Bosinger SE, Douek DC, Schreiber G, et al
Harnessing the power of IFN for therapeutic approaches to COVID-19.
J Virol. 2024 Apr 23:e0120423. doi: 10.1128/jvi.01204.
PubMed Abstract available

MAO D, Liu S, Phan AT, Renner S, et al
The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection.
J Virol. 2024 Apr 23:e0034724. doi: 10.1128/jvi.00347.
PubMed Abstract available

HAN Y, Yuan Z, Yi Z
Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349.
PubMed Abstract available

BOUGON J, Kadijk E, Gallot-Lavallee L, Curtis BA, et al
Influenza A virus NS1 effector domain is required for PA-X-mediated host shutoff in infected cells.
J Virol. 2024 Apr 17:e0190123. doi: 10.1128/jvi.01901.
PubMed Abstract available

PEREZ DR
A devastating blow: personal reflections on Argentina's scientific decline.
J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
PubMed Abstract available

ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
PubMed Abstract available

TAKADA K, Orba Y, Kida Y, Wu J, et al
Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784.
PubMed Abstract available

BU H, Zhang S, Li P, Liu Z, et al
Secreted phospholipase PLA2G2E contributes to regulation of T cell immune response against influenza virus infection.
J Virol. 2024 Apr 9:e0019824. doi: 10.1128/jvi.00198.
PubMed Abstract available

BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al
Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903.
PubMed Abstract available

YANG R, Han P, Han P, Li D, et al
Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451.
PubMed Abstract available

XIAO X, Fu Y, You W, Huang C, et al
Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573.
PubMed Abstract available

MAES A, Botzki A, Mathys J, Impens F, et al
Systematic review and meta-analysis of genome-wide pooled CRISPR screens to identify host factors involved in influenza A virus infection.
J Virol. 2024 Apr 3:e0185723. doi: 10.1128/jvi.01857.
PubMed Abstract available

SILVA F, Boal-Carvalho I, Williams N, Chabert M, et al
Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3.
J Virol. 2024 Apr 3:e0041124. doi: 10.1128/jvi.00411.
PubMed Abstract available

KEOWN J, Baazaoui A, Sebesta M, Stefl R, et al
Structural and functional characterization of the interaction between the influenza A virus RNA polymerase and the CTD of host RNA polymerase II.
J Virol. 2024 Apr 2:e0013824. doi: 10.1128/jvi.00138.
PubMed Abstract available

BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
PubMed Abstract available

NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
PubMed Abstract available

March 2024

MAI F, Bergmann W, Reisinger EC, Muller-Hilke B, et al
The varying extent of humoral and cellular immune responses to either vector- or RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent of infection.
J Virol. 2024 Mar 19:e0191223. doi: 10.1128/jvi.01912.
PubMed Abstract available

BABOT M, Boulard Y, Agouda S, Pieri L, et al
Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2 nsp3.
J Virol. 2024 Mar 14:e0157523. doi: 10.1128/jvi.01575.
PubMed Abstract available

SPRUIT CM, Palme DI, Li T, Rios Carrasco M, et al
Complex N-glycans are important for interspecies transmission of H7 influenza A viruses.
J Virol. 2024 Mar 12:e0194123. doi: 10.1128/jvi.01941.
PubMed Abstract available

HEINDL MR, Rupp A-L, Schwerdtner M, Bestle D, et al
ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
J Virol. 2024 Mar 12:e0010224. doi: 10.1128/jvi.00102.
PubMed Abstract available

WEN F, Yan Z, Chen G, Chen Y, et al
Recent H9N2 avian influenza virus lost hemagglutination activity due to a K141N substitution in hemagglutinin.
J Virol. 2024 Mar 11:e0024824. doi: 10.1128/jvi.00248.
PubMed Abstract available

ZHENG T, Shen B, Bai Y, Li E, et al
The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association.
J Virol. 2024 Mar 6:e0156523. doi: 10.1128/jvi.01565.
PubMed Abstract available

February 2024

ZHANG M, Liu M, Chen H, Qiu T, et al
PB2 residue 473 contributes to the mammalian virulence of H7N9 avian influenza virus by modulating viral polymerase activity via ANP32A.
J Virol. 2024 Feb 29:e0194423. doi: 10.1128/jvi.01944.
PubMed Abstract available

MARTINS M, Nooruzzaman M, Cunningham JL, Ye C, et al
The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.
J Virol. 2024 Feb 29:e0190223. doi: 10.1128/jvi.01902.
PubMed Abstract available

HAN J, Chang W, Fang J, Hou X, et al
The H9N2 avian influenza virus increases APEC adhesion to oviduct epithelia by viral NS1 protein-mediated activation of the TGF-beta pathway.
J Virol. 2024 Feb 28:e0151223. doi: 10.1128/jvi.01512.
PubMed Abstract available

UPRETY T, Yu J, Nogales A, Naveed A, et al
Influenza D virus utilizes both 9-O-acetylated N-acetylneuraminic and 9-O-acetylated N-glycolylneuraminic acids as functional entry receptors.
J Virol. 2024 Feb 20:e0004224. doi: 10.1128/jvi.00042.
PubMed Abstract available

NIE L, Huang Y, Cheng Z, Luo H, et al
An intranasal influenza virus vector vaccine protects against Helicobacter pylori in mice.
J Virol. 2024 Feb 15:e0192323. doi: 10.1128/jvi.01923.
PubMed Abstract available

ZENG J, Du F, Xiao L, Sun H, et al
Spatiotemporal genotype replacement of H5N8 avian influenza viruses contributed to H5N1 emergence in 2021/2022 panzootic.
J Virol. 2024 Feb 15:e0140123. doi: 10.1128/jvi.01401.
PubMed Abstract available

THOMAS MN, Zanella GC, Cowan B, Caceres CJ, et al
Nucleoprotein reassortment enhanced transmissibility of H3 1990.4.a clade influenza A virus in swine.
J Virol. 2024 Feb 14:e0170323. doi: 10.1128/jvi.01703.
PubMed Abstract available

KATAYAMA M, Murakami S, Ishida H, Matsugo H, et al
Antigenic commonality and divergence of hemagglutinin-esterase-fusion protein among influenza D virus lineages revealed using epitope mapping.
J Virol. 2024 Feb 12:e0190823. doi: 10.1128/jvi.01908.
PubMed Abstract available

VANSLAMBROUCK JM, Neil JA, Rudraraju R, Mah S, et al
Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection.
J Virol. 2024 Feb 9:e0180223. doi: 10.1128/jvi.01802.
PubMed Abstract available

SHINGAI M, Iida S, Kawai N, Kawahara M, et al
Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire.
J Virol. 2024 Feb 7:e0199523. doi: 10.1128/jvi.01995.
PubMed Abstract available

YANG Q, Barbachano-Guerrero A, Fairchild LM, Rowland TJ, et al
Macrophages derived from human induced pluripotent stem cells (iPSCs) serve as a high-fidelity cellular model for investigating HIV-1, dengue, and influenza viruses.
J Virol. 2024 Feb 7:e0156323. doi: 10.1128/jvi.01563.
PubMed Abstract available

LI H, Sun H, Tao M, Han Q, et al
Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses.
J Virol. 2024 Feb 2:e0112923. doi: 10.1128/jvi.01129.
PubMed Abstract available

NIU S, Zhao Z, Liu Z, Rong X, et al
Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
J Virol. 2024 Feb 2:e0115723. doi: 10.1128/jvi.01157.
PubMed Abstract available

BRICKER TL, Joshi A, Soudani N, Scheaffer SM, et al
Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
J Virol. 2024 Feb 2:e0120623. doi: 10.1128/jvi.01206.
PubMed Abstract available

HSIEH M-S, Hsu C-W, Liao H-C, Lin C-L, et al
SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
J Virol. 2024 Feb 1:e0154623. doi: 10.1128/jvi.01546.
PubMed Abstract available

January 2024

ROWE T, Davis W, Wentworth DE, Ross T, et al
Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells.
J Virol. 2024 Jan 31:e0149423. doi: 10.1128/jvi.01494.
PubMed Abstract available

SHEN S, Guo H, Li Y, Zhang L, et al
SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis.
J Virol. 2024 Jan 30:e0190923. doi: 10.1128/jvi.01909.
PubMed Abstract available

KIERAN TJ, Sun X, Maines TR, Beauchemin CAA, et al
Exploring associations between viral titer measurements and disease outcomes in ferrets inoculated with 125 contemporary influenza A viruses.
J Virol. 2024 Jan 19:e0166123. doi: 10.1128/jvi.01661.
PubMed Abstract available

DULIN H, Barre RS, Xu D, Neal A, et al
Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
J Virol. 2024 Jan 11:e0157123. doi: 10.1128/jvi.01571.
PubMed Abstract available

HE Y, Guo Z, Subiaur S, Benegal A, et al
Antibody inhibition of influenza A virus assembly and release.
J Virol. 2024 Jan 5:e0139823. doi: 10.1128/jvi.01398.
PubMed Abstract available

DEY S, Mondal A
Unveiling the role of host kinases at different steps of influenza A virus life cycle.
J Virol. 2024 Jan 4:e0119223. doi: 10.1128/jvi.01192.
PubMed Abstract available

FARJO M, Koelle K, Martin MA, Gibson LL, et al
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection.
J Virol. 2024 Jan 4:e0161823. doi: 10.1128/jvi.01618.
PubMed Abstract available

LI K, Verma A, Li P, Ortiz ME, et al
Adaptation of SARS-CoV-2 to ACE2(H353K) mice reveals new spike residues that drive mouse infection.
J Virol. 2024 Jan 3:e0151023. doi: 10.1128/jvi.01510.
PubMed Abstract available

RASMUSSEN AL, Gronvall GK, Lowen AC, Goodrum F, et al
Virology-the path forward.
J Virol. 2024 Jan 3:e0179123. doi: 10.1128/jvi.01791.
PubMed Abstract available

December 2023

BOLLAND W, Michel V, Planas D, Hubert M, et al
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.
J Virol. 2023 Dec 13:e0135123. doi: 10.1128/jvi.01351.
PubMed Abstract available

JERONIMO PMC, Aksenen CF, Duarte IO, Lins RD, et al
Evolutionary deletions within the SARS-CoV-2 genome as signature trends for virus fitness and adaptation.
J Virol. 2023 Dec 13:e0140423. doi: 10.1128/jvi.01404.
PubMed Abstract available

ZHANG L, Shao Y, Wang Y, Yang Q, et al
Twenty natural amino acid substitution screening at the last residue 121 of influenza A virus NS2 protein reveals the critical role of NS2 in promoting virus genome replication by coordinating with viral polymerase.
J Virol. 2023 Dec 6:e0116623. doi: 10.1128/jvi.01166.
PubMed Abstract available

PHAM TX, Huynh TTX, Choi J, Lee J-B, et al
SARS-CoV-2 exploits cellular RAD51 to promote viral propagation: implication of RAD51 inhibitor as a potential drug candidate against COVID-19.
J Virol. 2023 Dec 5:e0173723. doi: 10.1128/jvi.01737.
PubMed Abstract available

ZAYOU L, Prakash S, Dhanushkodi NR, Quadiri A, et al
A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4(+) and CD8(+) T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection.
J Virol. 2023 Dec 1:e0109623. doi: 10.1128/jvi.01096.
PubMed Abstract available

November 2023

LI K, Huntwork RHC, Horn GQ, Abraha M, et al
Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.
J Virol. 2023 Nov 29:e0107023. doi: 10.1128/jvi.01070.
PubMed Abstract available

DOMINGO E, Martinez-Gonzalez B, Garcia-Crespo C, Somovilla P, et al
Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.
J Virol. 2023 Nov 21:e0151123. doi: 10.1128/jvi.01511.
PubMed Abstract available

BRAGAZZI CUNHA J, Leix K, Sherman EJ, Mirabelli C, et al
Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection.
J Virol. 2023 Nov 17:e0127623. doi: 10.1128/jvi.01276.
PubMed Abstract available

ALRUWAILI M, Armstrong S, Prince T, Erdmann M, et al
SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption.
J Virol. 2023 Nov 6:e0042423. doi: 10.1128/jvi.00424.
PubMed Abstract available

SUN W, Xu J, Wang Z, Li D, et al
Clade 2.3.4.4 H5 chimeric cold-adapted attenuated influenza vaccines induced cross-reactive protection in mice and ferrets.
J Virol. 2023 Nov 2:e0110123. doi: 10.1128/jvi.01101.
PubMed Abstract available

RIJNINK WF, Stadlbauer D, Puente-Massaguer E, Okba NMA, et al
Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses.
J Virol. 2023 Nov 2:e0164622. doi: 10.1128/jvi.01646.
PubMed Abstract available

October 2023

PAHMEIER F, Lavacca T-M, Goellner S, Neufeldt CJ, et al
Identification of host dependency factors involved in SARS-CoV-2 replication organelle formation through proteomics and ultrastructural analysis.
J Virol. 2023 Oct 31:e0087823. doi: 10.1128/jvi.00878.
PubMed Abstract available

CAO J, Shi M, Zhu L, Li X, et al
The matrix protein of respiratory syncytial virus suppresses interferon signaling via RACK1 association.
J Virol. 2023;97:e0074723.
PubMed Abstract available

BARTSCH YC, Cizmeci D, Yuan D, Mehta N, et al
Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine.
J Virol. 2023 Oct 30:e0077123. doi: 10.1128/jvi.00771.
PubMed Abstract available

LI Y, Arcos S, Sabsay KR, Te Velthuis AJW, et al
Deep mutational scanning reveals the functional constraints and evolutionary potential of the influenza A virus PB1 protein.
J Virol. 2023 Oct 26:e0132923. doi: 10.1128/jvi.01329.
PubMed Abstract available

YAN Z, Li Y, Huang S, Wen F, et al
Global distribution, receptor binding, and cross-species transmission of H6 influenza viruses: risks and implications for humans.
J Virol. 2023 Oct 25:e0137023. doi: 10.1128/jvi.01370.
PubMed Abstract available

UNDI RB, Ahsan N, Larabee JL, Darlene-Reuter N, et al
Blocking of doublecortin-like kinase 1-regulated SARS-CoV-2 replication cycle restores cell signaling network.
J Virol. 2023 Oct 20:e0119423. doi: 10.1128/jvi.01194.
PubMed Abstract available

KUMAR S, Delipan R, Chakraborty D, Kanjo K, et al
Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity.
J Virol. 2023 Oct 20:e0092223. doi: 10.1128/jvi.00922.
PubMed Abstract available

YE G, Pan R, Bu F, Zheng J, et al
Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.
J Virol. 2023 Oct 19:e0144823. doi: 10.1128/jvi.01448.
PubMed Abstract available

SUN H, Wang Y, Chen X, Jiang Y, et al
Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant.
J Virol. 2023 Oct 19:e0113723. doi: 10.1128/jvi.01137.
PubMed Abstract available

JOHNSON RM, Ardanuy J, Hammond H, Logue J, et al
Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2.
J Virol. 2023 Oct 17:e0133623. doi: 10.1128/jvi.01336.
PubMed Abstract available

LIANG CY, Huang I, Han J, Sownthirarajan B, et al
Avian influenza A viruses exhibit plasticity in sialylglycoconjugate receptor usage in human lung cells.
J Virol. 2023 Oct 16:e0090623. doi: 10.1128/jvi.00906.
PubMed Abstract available

WU Y, Shi J, He X, Lu J, et al
Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.
J Virol. 2023 Oct 16:e0127923. doi: 10.1128/jvi.01279.
PubMed Abstract available

MISPLON JA, Lo CY, Crabbs TA, Price GE, et al
Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination.
J Virol. 2023 Oct 13:e0067423. doi: 10.1128/jvi.00674.
PubMed Abstract available

MIURA K, Suzuki Y, Ishida K, Arakawa M, et al
Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells.
J Virol. 2023 Oct 13:e0042623. doi: 10.1128/jvi.00426.
PubMed Abstract available

MAHE D, Bourgeau S, da Silva J, Schlederer J, et al
SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivo.
J Virol. 2023 Oct 13:e0110423. doi: 10.1128/jvi.01104.
PubMed Abstract available

RIBO-MOLINA P, Weiss HJ, Susma B, van Nieuwkoop S, et al
4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1.
J Virol. 2023 Oct 12:e0132523. doi: 10.1128/jvi.01325.
PubMed Abstract available

ISELI AN, Pohl MO, Glas I, Gaggioli E, et al
The neuraminidase activity of influenza A virus determines the strain-specific sensitivity to neutralization by respiratory mucus.
J Virol. 2023 Oct 11:e0127123. doi: 10.1128/jvi.01271.
PubMed Abstract available

GIRARD J, Jakob C, Toews LK, Fuchs J, et al
Disruption of influenza virus packaging signals results in various misassembled genome complexes.
J Virol. 2023 Oct 9:e0107623. doi: 10.1128/jvi.01076.
PubMed Abstract available

CARNACCINI S, Caceres CJ, Gay LC, Ferreri LM, et al
Antigenic mapping of the hemagglutinin of the H9 subtype influenza A viruses using sera from Japanese quail (Coturnix c. japonica).
J Virol. 2023 Oct 6:e0074323. doi: 10.1128/jvi.00743.
PubMed Abstract available

MCMAHON M, Tan J, O'Dell G, Kirkpatrick Roubidoux E, et al
Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner.
J Virol. 2023 Oct 6:e0105723. doi: 10.1128/jvi.01057.
PubMed Abstract available

KIMURA I, Yamasoba D, Nasser H, Ito H, et al
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
J Virol. 2023 Oct 5:e0101123. doi: 10.1128/jvi.01011.
PubMed Abstract available

MENG X, Veit M
Palmitoylation of the hemagglutinin of influenza B virus by ER-localized DHHC enzymes 1, 2, 4, and 6 is required for efficient virus replication.
J Virol. 2023 Oct 4:e0124523. doi: 10.1128/jvi.01245.
PubMed Abstract available

September 2023

ZHAO Y, Sui L, Wu P, Li L, et al
EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8.
J Virol. 2023 Sep 29:e0102823. doi: 10.1128/jvi.01028.
PubMed Abstract available

LI J, Gui Q, Liang FX, Sall J, et al
The REEP5/TRAM1 complex binds SARS-CoV-2 NSP3 and promotes virus replication.
J Virol. 2023 Sep 28:e0050723. doi: 10.1128/jvi.00507.
PubMed Abstract available

NENNA R, Stern DA, Carr TF, Spangenberg A, et al
Prenatal exposure to RSV season influences first-year risk of RSV lower respiratory illness and RSV-specific immune responses assessed at birth.
J Virol. 2023;97:e0076723.
PubMed Abstract available

WALLACE LE, de Vries E, van Kuppeveld FJM, de Haan CAM, et al
Neuraminidase-dependent entry of influenza A virus is determined by hemagglutinin receptor-binding specificity.
J Virol. 2023 Sep 27:e0060223. doi: 10.1128/jvi.00602.
PubMed Abstract available

MCCOOL RS, Musayev M, Bush SM, Derrien-Colemyn A, et al
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitope.
J Virol. 2023 Sep 22:e0092923. doi: 10.1128/jvi.00929.
PubMed Abstract available

SCHOEN A, Holzer M, Muller MA, Wallerang KB, et al
Functional comparisons of the virus sensor RIG-I from humans, the microbat Myotis daubentonii, and the megabat Rousettus aegyptiacus, and their response to SARS-CoV-2 infection.
J Virol. 2023 Sep 20:e0020523. doi: 10.1128/jvi.00205.
PubMed Abstract available

FUJITA S, Kosugi Y, Kimura I, Tokunaga K, et al
Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2.
J Virol. 2023 Sep 19:e0099023. doi: 10.1128/jvi.00990.
PubMed Abstract available

XING M, Wang Y, Wang X, Liu J, et al
Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants.
J Virol. 2023 Sep 14:e0072423. doi: 10.1128/jvi.00724.
PubMed Abstract available

CASE JB, Scheaffer SM, Darling TL, Bricker TL, et al
Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
J Virol. 2023 Sep 7:e0062823. doi: 10.1128/jvi.00628.
PubMed Abstract available

August 2023

LIN HF, Liu MQ, Jiang RD, Gong QC, et al
Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus.
J Virol. 2023 Aug 21:e0079023. doi: 10.1128/jvi.00790.
PubMed Abstract available

LEONARD RA, Rao VN, Bartlett A, Froggatt HM, et al
A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases.
J Virol. 2023 Aug 14:e0059723. doi: 10.1128/jvi.00597.
PubMed Abstract available

JIN H, Cheng L, Gong Y, Zhu Y, et al
Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
J Virol. 2023 Aug 14:e0019223. doi: 10.1128/jvi.00192.
PubMed Abstract available

ZHANG W, Shi K, Geng Q, Herbst M, et al
Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
J Virol. 2023 Aug 14:e0082223. doi: 10.1128/jvi.00822.
PubMed Abstract available

LLEWELLYN GN, Chen HY, Rogers GL, Huang X, et al
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.
J Virol. 2023 Aug 9:e0068423. doi: 10.1128/jvi.00684.
PubMed Abstract available

MYKYTYN AZ, Breugem TI, Geurts MH, Beumer J, et al
SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models.
J Virol. 2023 Aug 9:e0085123. doi: 10.1128/jvi.00851.
PubMed Abstract available

THOMPSON D, Cismaru CV, Rougier JS, Schwemmle M, et al
The M2 proteins of bat influenza A viruses reveal atypical features compared to conventional M2 proteins.
J Virol. 2023 Aug 4:e0038823. doi: 10.1128/jvi.00388.
PubMed Abstract available

July 2023

TALUKDAR SN, McGregor B, Osan JK, Hur J, et al
Respiratory Syncytial Virus Infection Does Not Induce Epithelial-Mesenchymal Transition.
J Virol. 2023;97:e0039423.
PubMed Abstract available

HICKERSON BT, Petrovskaya SN, Dickensheets H, Donnelly RP, et al
Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility.
J Virol. 2023 Jul 5:e0015423. doi: 10.1128/jvi.00154.
PubMed Abstract available

JENSEN JL, Sankhala RS, Dussupt V, Bai H, et al
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
J Virol. 2023 Jul 3:e0159622. doi: 10.1128/jvi.01596.
PubMed Abstract available

June 2023

HUANG J, Chen Z, Ye Y, Shao Y, et al
DTX3L Enhances Type I Interferon Antiviral Response by Promoting the Ubiquitination and Phosphorylation of TBK1.
J Virol. 2023;97:e0068723.
PubMed Abstract available

YANG X, Duan H, Liu X, Zhang X, et al
Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
J Virol. 2023 Jun 27:e0061023. doi: 10.1128/jvi.00610.
PubMed Abstract available

TERASAKI K, Narayanan K, Makino S
Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.
J Virol. 2023 Jun 27:e0065923. doi: 10.1128/jvi.00659.
PubMed Abstract available

LI A, Zhang B, Zhao K, Yin Z, et al
SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
J Virol. 2023 Jun 22:e0051223. doi: 10.1128/jvi.00512.
PubMed Abstract available

GOFFIN E, Du X, Hemmi S, Machiels B, et al
A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.
J Virol. 2023 Jun 20:e0013523. doi: 10.1128/jvi.00135.
PubMed Abstract available

CHEN P, Jin Z, Peng L, Zheng Z, et al
Characterization of an Emergent Chicken H3N8 Influenza Virus in Southern China: a Potential Threat to Public Health.
J Virol. 2023 Jun 8:e0043423. doi: 10.1128/jvi.00434.
PubMed Abstract available

ZHENG H, Ma L, Gui R, Lin X, et al
Correction for Zheng et al., "G Protein Subunit beta1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2".
J Virol. 2023 Jun 6:e0054623. doi: 10.1128/jvi.00546.
PubMed

May 2023

WANG C, Honce R, Salvatore M, Chow D, et al
Influenza Defective Interfering Virus Promotes Multiciliated Cell Differentiation and Reduces the Inflammatory Response in Mice.
J Virol. 2023 May 31:e0049323. doi: 10.1128/jvi.00493.
PubMed Abstract available

RUNSTADLER JA, Lowen AC, Kayali G, Tompkins SM, et al
Field Research Is Essential to Counter Virological Threats.
J Virol. 2023;97:e0054423.
PubMed Abstract available

REZENDE W, Ye X, Angelo LS, Carisey AF, et al
The Efficiency of p27 Cleavage during In Vitro Respiratory Syncytial Virus (RSV) Infection Is Cell Line and RSV Subtype Dependent.
J Virol. 2023;97:e0025423.
PubMed Abstract available

SREENIVASAN CC, Liu R, Gao R, Guo Y, et al
Influenza C and D Viruses Demonstrated a Differential Respiratory Tissue Tropism in a Comparative Pathogenesis Study in Guinea Pigs.
J Virol. 2023 May 18:e0035623. doi: 10.1128/jvi.00356.
PubMed Abstract available

JIANG H, Joshi A, Gan T, Janowski AB, et al
The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2.
J Virol. 2023 May 18:e0063523. doi: 10.1128/jvi.00635.
PubMed Abstract available

SLANINA H, Madhugiri R, Wenk K, Reinke T, et al
Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains.
J Virol. 2023 May 18:e0046523. doi: 10.1128/jvi.00465.
PubMed Abstract available

ISHIMARU H, Nishimura M, Tjan LH, Sutandhio S, et al
Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants.
J Virol. 2023 May 16:e0028623. doi: 10.1128/jvi.00286.
PubMed Abstract available

ZHANG L, Wang Y, Shao Y, Guo J, et al
Fine Regulation of Influenza Virus RNA Transcription and Replication by Stoichiometric Changes in Viral NS1 and NS2 Proteins.
J Virol. 2023 May 11:e0033723. doi: 10.1128/jvi.00337.
PubMed Abstract available

SENGAR A, Cervantes M, Bondalapati ST, Hess T, et al
Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry.
J Virol. 2023 May 3:e0199222. doi: 10.1128/jvi.01992.
PubMed Abstract available

April 2023

SPECK P, Mackenzie J, Bull RA, Slobedman B, et al
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
J Virol. 2023 Apr 25:e0045123. doi: 10.1128/jvi.00451.
PubMed

PEACOCK TP, Sheppard CM, Lister MG, Staller E, et al
Mammalian ANP32A and ANP32B Proteins Drive Differential Polymerase Adaptations in Avian Influenza Virus.
J Virol. 2023 Apr 19:e0021323. doi: 10.1128/jvi.00213.
PubMed Abstract available

KETTUNEN P, Lesnikova A, Rasanen N, Ojha R, et al
SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
J Virol. 2023 Apr 11:e0014423. doi: 10.1128/jvi.00144.
PubMed Abstract available

LIN SJ, Lin KM, Chen SJ, Ku CC, et al
Type I Interferon Orchestrates Demand-Adapted Monopoiesis during Influenza A Virus Infection via STAT1-Mediated Upregulation of Macrophage Colony-Stimulating Factor Receptor Expression.
J Virol. 2023 Apr 6:e0010223. doi: 10.1128/jvi.00102.
PubMed Abstract available

March 2023

TAN Y, Shilts MH, Rosas-Salazar C, Puri V, et al
Influence of Sex on Respiratory Syncytial Virus Genotype Infection Frequency and Nasopharyngeal Microbiome.
J Virol. 2023;97:e0147222.
PubMed Abstract available

ALWINE JC, Casadevall A, Enquist LW, Goodrum FD, et al
A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses.
J Virol. 2023 Mar 10:e0036523. doi: 10.1128/jvi.00365.
PubMed Abstract available

WANG X, Wang W, Wang T, Wang J, et al
SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
J Virol. 2023 Mar 6:e0001123. doi: 10.1128/jvi.00011.
PubMed Abstract available

MOLS VC, Lamers MM, Leijten LM, Breugem TI, et al
Intestinal Tropism of a Betacoronavirus (Merbecovirus) in Nathusius's Pipistrelle Bat (Pipistrellus nathusii), Its Natural Host.
J Virol. 2023 Mar 1:e0009923. doi: 10.1128/jvi.00099.
PubMed Abstract available

February 2023

FROLOV I, Agback T, Palchevska O, Dominguez F, et al
All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity of the Protein.
J Virol. 2023 Feb 27:e0186522. doi: 10.1128/jvi.01865.
PubMed Abstract available

ZHANG L, Hom N, Ojha A, Lovendahl KN, et al
Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions.
J Virol. 2023 Feb 15:e0165022. doi: 10.1128/jvi.01650.
PubMed Abstract available

WANG X, Wen Z, Cao H, Luo J, et al
Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.
J Virol. 2023 Feb 13:e0161122. doi: 10.1128/jvi.01611.
PubMed Abstract available

WANG Y, Ge F, Wang J, Li H, et al
Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
J Virol. 2023 Feb 13:e0176422. doi: 10.1128/jvi.01764.
PubMed Abstract available

AMANAT F, Clark J, Carreno JM, Strohmeier S, et al
Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
J Virol. 2023 Feb 13:e0166422. doi: 10.1128/jvi.01664.
PubMed Abstract available

BEI C, Zhang C, Wu H, Feng H, et al
DDX3X Is Hijacked by Snakehead Vesiculovirus Phosphoprotein To Facilitate Virus Replication via Stabilization of the Phosphoprotein.
J Virol. 2023 Feb 6:e0003523. doi: 10.1128/jvi.00035.
PubMed Abstract available

SCHINDEWOLF C, Lokugamage K, Vu MN, Johnson BA, et al
SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
J Virol. 2023 Feb 1:e0153222. doi: 10.1128/jvi.01532.
PubMed Abstract available

January 2023

GOODRUM F, Lowen A, Lakdawala S, Alwine J, et al
Virology under the Microscope-a Call for Rational Discourse.
J Virol. 2023 Jan 26:e0008923. doi: 10.1128/jvi.00089.
PubMed Abstract available

LIU MQ, Lin HF, Li J, Chen Y, et al
A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice.
J Virol. 2023 Jan 23:e0171922. doi: 10.1128/jvi.01719.
PubMed Abstract available

RAJAGOPALA SV, Strickland BA, Pakala SB, Kimura KS, et al
Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
J Virol. 2023 Jan 19:e0147822. doi: 10.1128/jvi.01478.
PubMed Abstract available

MA J, Liu X, Zhou M, Chen P, et al
A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
J Virol. 2023 Jan 18:e0168422. doi: 10.1128/jvi.01684.
PubMed Abstract available

September 2021

TANG W, Li Y, Song Q, Wang Z, et al
Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein.
J Virol. 2021;95:e0120521.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.